| Authors: |
Heier JS; aOphthalmic Consultants of Boston, Boston, MA, USA., Lad EM; bDepartment of Ophthalmology, Duke University Medical Center, Durham, NC, USA., Holz FG; cDepartment of Ophthalmology, University of Bonn, Bonn, Germany., Rosenfeld PJ; dDepartment of Ophthalmology, University of Miami, Miami, FL, USA., Guymer RH; eCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia., Boyer D; fRetina Vitreous Associates Medical Group, Los Angeles, CA, USA., Grossi F; gApellis Pharmaceuticals, Waltham, MA,USA., Baumal CR; gApellis Pharmaceuticals, Waltham, MA,USA., Korobelnik JF; hService d'Ophtalmologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.; iOphthalmology Department, University of Bordeaux, Bordeaux,France., Slakter JS; jDepartment of Ophthalmology, New York University, New York, NY, USA., Waheed NK; kNew England Eye Center, Boston, MA, USA., Metlapally R; gApellis Pharmaceuticals, Waltham, MA,USA., Pearce I; llDepartment of Ophthalmology Royal Liverpool University Hospital, Liverpool, UK., Steinle N; mCalifornia Retina Consultants, Santa Barbara, CA, USA., Francone AA; nCharles Centro Oftalmológico, Buenos Aires, Argentina., Hu A; oCumberland Valley Retina Consultants, Hagerstown, MD, USA., Lally DR; pNew England Retina Consultants, Springfield, MA, USA., Deschatelets P; gApellis Pharmaceuticals, Waltham, MA,USA., Francois C; gApellis Pharmaceuticals, Waltham, MA,USA., Bliss C; gApellis Pharmaceuticals, Waltham, MA,USA., Staurenghi G; qDepartment of Biomedical and Clinical Science, Ospedale Luigi Sacco University of Milan, Milan, Italy., Monés J; rInstitut de la Màcula, Centro Médico Teknon and Barcelona Macula Foundation: Research for Vision,Centro Médico Teknon, Barcelona, Spain., Singh RP; sCenter for Ophthalmic Bioinformatics, Cleveland Clinic, Cleveland, OH, USA., Ribeiro R; gApellis Pharmaceuticals, Waltham, MA,USA., Wykoff CC; tRetina Consultants of Texas, Blanton Eye Institute, and Houston Methodist Hospital, Houston, TX, USA. |
